Showing 1 of 1 recruiting trials for “epidermolysis-bullosa-simplex-without-extracutaneous-involvement”
A 44-week Monocentric Open Study Assessing the Efficacy and Safety of Deucravacitinib in Adults With Inflammatory Genodermatoses
👨⚕️ Christine Chiaverini, Centre Hospitalier Universitaire de Nice📍 2 sites📅 Started Mar 2024View details ↗
Get alerts when new trials open
Create a free account to follow conditions and receive trial notifications.
Create free account →